Paul O'Connell Selected Research

Osilodrostat

12/2022	Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2).
1/2020	Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul O'Connell Research Topics

Disease

3	Neoplasms (Cancer) 10/2023 - 01/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2017 - 07/2013
2	Arthritis (Polyarthritis) 10/2023 - 01/2021
2	Lung Diseases (Lung Disease) 10/2023 - 01/2022
2	Gout 10/2023 - 01/2022
2	Pituitary ACTH Hypersecretion 12/2022 - 01/2020
2	Cushing Syndrome 12/2022 - 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Obesity 10/2023
1	Hirsutism 12/2022
1	Cognitive Dysfunction 01/2018
1	Inflammation (Inflammations) 05/2017
1	Rheumatoid Arthritis 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 01/2016
1	Schizophrenia (Dementia Praecox) 01/2016
1	Adjustment Disorders (Adjustment Disorder) 11/2015

Drug/Important Bio-Agent (IBA)

3	GlucocorticoidsIBA 10/2023 - 01/2021
2	OsilodrostatIBA 12/2022 - 01/2020
1	Antirheumatic Agents (DMARD)IBA 10/2023
1	Testosterone (Sustanon)FDA Link 12/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2020
1	pristane (pristan)IBA 05/2017
1	Interferon Type IIBA 05/2017
1	acetyl 4-aminosalicylic acidIBA 01/2017
1	Rheumatoid FactorIBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Antinuclear AntibodiesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Fibrinolysin FDA Link 01/2016
1	CytokinesIBA 09/2014
1	B-Cell Activating FactorIBA 07/2013

Therapy/Procedure

2	Therapeutics 12/2022 - 01/2016
2	Length of Stay 01/2018 - 11/2015
1	Biological Therapy 05/2017